Research > Apply For a Grant
2016 CURE Innovator Award
The CURE Innovator Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to epilepsy. The Innovator Award is not intended to support a logical progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue innovative research ideas. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Research completed through an Innovator Award strives to provide sufficient preliminary data to enable the PI to test a groundbreaking, original, and/or unconventional hypothesis and has the potential, if successful, to open new areas for epilepsy research.
Preliminary data is not necessary to receive this grant.
Areas of Interest:This program awards seed grants to researchers submitting innovative proposals that will provide new directions for epilepsy therapy, prevention and, ultimately, a cure. We specifically encourage studies that may not be currently fundable by other agencies, such as the National Institutes of Health, because of their preliminary or unconventional nature.
Eligibility: This award is available to both established and early career investigators*. Researchers who serve on CURE’s Scientific Advisory Council are ineligible to apply for or sponsor a grant for the duration of their term. International applicants are welcome. All materials must be submitted in English.
* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above. In exceptional cases, scientists at the postdoctoral level may be eligible for this award.
Budget: Requests may be made for up to $50,000 for one year. Indirect costs are not supported.
Letter of Intent:All applicants must submit a Letter of Intent (LOI). The LOI should clearly and succinctly outline the hypothesis to be tested, the specific aims, and provide a brief description of how the proposed research plan, if successful, meets the goals of the Innovator Award. All LOIs are evaluated by scientific reviewers and the Lay Review Council, with the final decisions as to who will be invited to submit full proposals made by the CURE Board of Directors.
|2016 FUNDING CYCLE
Deadline for Receipt of LOI: TBD
Deadline for Receipt of Full Application: TBD
Award Announcement: TBD
Earliest Project Start Date: TBD
|*We are changing our award cycles so timelines for 2016 are TBD. Please click here if you would like to be added to our Research eBlast list in order to be notified when the program reopens.